These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5126986)

  • 21. Gas chromatographic analysis of urinary volatile phenols in patients with gastro-intestinal disorders and normals.
    Duran M; Ketting D; de Bree PK; van der Heiden C; Wadman SK
    Clin Chim Acta; 1973 May; 45(4):341-7. PubMed ID: 4730205
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenylalanine o-hydroxy-phenylacetic acid phenylpyruvic acid equals phenylketonuric diagnosis. A report of studies made on 77 students in schools for mentally retarded.
    VEAL AR
    Am J Med Technol; 1961; 27():191-6. PubMed ID: 13780514
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simple method for study of tyrosyluria].
    Humbel R
    Pharm Acta Helv; 1968 Jan; 43(1):57-64. PubMed ID: 5719458
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method.
    Gentz J; Lindblad B; Lindstedt S; Zetterström R
    J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relations between serum phenylalanine level and phenylpyruvate and o-hydroxyphenylacetate in urine of patients with phenylketonuria, treated by diet].
    Zelnícek E; Podhradská O; Sláma J
    Bratisl Lek Listy; 1971; 55(1):63-9. PubMed ID: 5549026
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance of aryl-substituted phenylalanines to decarboxylation in the rat.
    Goodwin BL; Ruthven CR; Sandler M
    Gen Pharmacol; 1998 Sep; 31(3):437-40. PubMed ID: 9703215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phenylpyruvate and o-hydroxyphenylacetate in the urine of phenylketonurics treated by dietary measures].
    Zelnícek E; Podhradská O; Sláma J
    Z Kinderheilkd; 1970; 108(3):258-64. PubMed ID: 5475034
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
    Mokhtarani M; Diaz GA; Rhead W; Lichter-Konecki U; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Vockley J; Bart S; Kronn D; Zori R; Cederbaum S; Dorrani N; Merritt JL; Sreenath-Nagamani S; Summar M; Lemons C; Dickinson K; Coakley DF; Moors TL; Lee B; Scharschmidt BF
    Mol Genet Metab; 2012 Nov; 107(3):308-14. PubMed ID: 22958974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of age on ortho-hydroxyphenylacetic acid excretion in phenylketonuria and its genetic variants.
    Rey F; Pellié C; Sivy M; Blandin-Savoja F; Rey J; Frézal J
    Pediatr Res; 1974 May; 8(5):540-5. PubMed ID: 4151091
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of diet upon the excretion of parahydroxy-phenylacetic acid and creatinine in man.
    Tocci PM; Phillips J; Sager R
    Clin Chim Acta; 1972 Sep; 40(2):449-53. PubMed ID: 5056144
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantitative studies on the urinary excretion of unconjugated aromatic acids in phenylketonuria.
    Chalmers RA; Watts RW
    Clin Chim Acta; 1974 Sep; 55(3):281-94. PubMed ID: 4415434
    [No Abstract]   [Full Text] [Related]  

  • 32. Permanent chemical phenylketonuria and a normal phenylalanine tolerance in two sisters with a normal mental development.
    Wadman SK; Ketting D; De Bree PK; Van der Heiden C; Grimberg MT; Kruijswijk H
    Clin Chim Acta; 1975 Dec; 65(2):197-204. PubMed ID: 1183053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
    Watts RW; Chalmers RA; Liberman MM; Lawson AM
    Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the possible neurotoxicity of metabolites of phenylalanine.
    Kaufman S
    J Pediatr; 1989 May; 114(5):895-900. PubMed ID: 2654351
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of a significant renal threshold for two aromatic acids in phenylketonuric children over two years of age.
    Langenbeck U; Behbehani A; Mench-Hoinowski A; Petersen M
    Eur J Pediatr; 1980 Aug; 134(2):115-8. PubMed ID: 7439195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 37. Sensitive fluorescence monitoring of aromatic acids after anion-exchange chromatography of body fluids.
    Katz S; Pitt WW; Jones G
    Clin Chem; 1973 Aug; 19(8):817-20. PubMed ID: 4720807
    [No Abstract]   [Full Text] [Related]  

  • 38. Aspects of tyrosine metabolism in schizophrenia.
    Williams CH
    Psychol Med; 1971 Aug; 1(4):286-91. PubMed ID: 5149869
    [No Abstract]   [Full Text] [Related]  

  • 39. An in vivo function of glucagon-induced phenylalanine: pyruvate transaminase in p-chlorophenylalanine-treated rats.
    Shih JC; Lien CC; Malcolm RD
    Arch Biochem Biophys; 1982 Apr; 215(1):66-71. PubMed ID: 6212025
    [No Abstract]   [Full Text] [Related]  

  • 40. Tyrosine metabolism in cystic fibrosis.
    Robinson R
    Clin Chim Acta; 1966 Aug; 14(2):166-70. PubMed ID: 5967164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.